Business Context and Reporting Period
Lunai Bioworks Inc. (LNAI), a Delaware corporation, filed this Form 8-K on February 6, 2026. The company is headquartered in Sacramento, California, and its common stock trades on The Nasdaq Capital Market.
Key Financial Metrics
This filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock listing status.
Material Changes
- Delisting Notice: The company received a notice from Nasdaq staff determining that its securities will be delisted from The Nasdaq Capital Market.
- Non-Compliance Reason: The company failed to maintain the minimum bid price of $1.00 per share required by Nasdaq Listing Rule 5550(a)(2). The stock closed below $1.00 for 30 consecutive business days from December 23, 2025, through February 5, 2026.
- Ineligibility for Compliance Period: The company is not eligible for the standard 180-day compliance period because it executed a 1-for-10 reverse stock split on September 30, 2025, within the prior one-year period (per Nasdaq Listing Rule 5810(c)(3)(A)(iv)).
Outlook, Risks, and Management Commentary
- Appeal Filed: The company has filed a request for a hearing before the Nasdaq Hearings Panel to appeal the delisting determination.
- Trading Status: The hearing request stays the suspension of trading and the filing of Form 25 pending the hearing outcome. Without a successful appeal, trading would be suspended on February 18, 2026.
- Risks: Management explicitly states there can be no assurance that the appeal will be successful or that the company will regain compliance with listing requirements.
Investor Verification Checklist
- Verify the outcome of the Nasdaq Hearings Panel appeal.
- Monitor the stock's bid price to assess if it can meet the $1.00 threshold in the future.
- Check for any subsequent filings regarding the potential transfer of listing to another exchange or the OTC market.
- Review the company's capital structure following the September 30, 2025, reverse stock split.